 | bluebird (BLUE) Gene Therapies BLA Decision Delayed, Stock Down
finance.yahoo.com - January 19 at 2:14 PM |
 | Vir Biotechnology (NASDAQ:VIR) Stock Price Down 4%
americanbankingnews.com - January 19 at 12:54 PM |
 | Vir to extend COVID-19 treatment approach to HIV, malaria with $50M from Gates Foundation
msn.com - January 14 at 3:50 PM |
| Glaxo (GSK), Vir Seek EUA for Intramuscular Sotrovimab in US
finance.yahoo.com - January 14 at 3:50 PM |
 | Eli Lilly and GlaxoSmithKline/Vir COVID-19 therapies get WHO backing
seekingalpha.com - January 14 at 6:58 AM |
| Vir Biotechnology, Inc. (NASDAQ:VIR) EVP Sells $48,262.50 in Stock
americanbankingnews.com - January 13 at 6:50 PM |
| Vir Biotechnology, Gates Foundation expand partnership for treating HIV, malaria
seekingalpha.com - January 13 at 1:02 PM |
| GlaxoSmithKline, Vir seek FDA nod for intramuscular use of COVID-19 therapy
seekingalpha.com - January 13 at 11:49 AM |
| Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for HIV and Prevention of Malaria
finance.yahoo.com - January 13 at 11:49 AM |
| Vir Biotechnology, Inc. (VIR) Soars 15.1%: Is Further Upside Left in the Stock?
finance.yahoo.com - January 13 at 6:29 AM |
| Vir extends gains as Needham lifts sales outlook for COVID-19 antibody therapy
seekingalpha.com - January 12 at 3:27 PM |
|
| Vir Biotechnology (NASDAQ:VIR) Shares Up 5.4%
americanbankingnews.com - January 12 at 2:21 PM |
| Vir Biotechnology, Inc. (VIR) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
finance.yahoo.com - January 12 at 11:56 AM |
| US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy
msn.com - January 11 at 2:46 PM |
| GSK, Vir to supply US government with 600,000 doses of Covid-19 drug
msn.com - January 11 at 1:50 PM |
| GlaxoSmithKline, Vir Say U.S. to Buy 600,000 More Covid Doses
msn.com - January 11 at 1:50 PM |
| Vir Biotechnology (NASDAQ:VIR) Shares Gap Up to $33.42
americanbankingnews.com - January 11 at 10:50 AM |
| U.S. secures 600,000 more doses of GSK-Vir's COVID-19 therapy
msn.com - January 11 at 9:45 AM |
 | GSK, Vir To Supply Additional 60k Doses Of Sotrovimab To US Govt. For Early Treatment Of Covid-19
markets.businessinsider.com - January 11 at 9:45 AM |
| Vir Biotechnology jumps 8% on purchase agreement of Sotrovimab with the US government
seekingalpha.com - January 11 at 9:45 AM |
| GSK, Vir to provide U.S. with 600K additional doses of COVID treatment sotrovimab
seekingalpha.com - January 11 at 9:45 AM |
| Tesla, Vir Biotechnology, Illumina Rise Premarket; Rivian Falls
msn.com - January 11 at 8:50 AM |
| GSK Signs Addl Purchase Agreements With Canada For COVID-19 Monoclonal Antibody Therapy, Sotrovimab
markets.businessinsider.com - January 6 at 11:34 PM |
| Notable Expands Executive Leadership Team with Appointment of Dr. Kevin Lynch as Chief Business Officer
finance.yahoo.com - January 6 at 6:33 PM |
| GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 doses
finance.yahoo.com - January 6 at 6:33 PM |
| Vir Biotechnology to Present at 40th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 5:32 PM |
 | Vir Biotechnology Announces New Research Describing Structural Basis Of SARS-CoV-2 Omicron Immune Evasion And Receptor Engagement
benzinga.com - December 31 at 11:16 AM |
| UPDATE: Vir Biotechnology Says Sotrovimab Continues To Maintain Activity Against All Tested Variants Of Concern And Interest, Including Omicron
benzinga.com - December 31 at 11:16 AM |
| Implied Volatility Surging for Vir Biotechnology (VIR) Stock Options
finance.yahoo.com - December 31 at 11:16 AM |
 | Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) EVP Sells 1,375 Shares of Stock
insidertrades.com - December 30 at 6:14 PM |
| GILD or VIR: Which Is the Better Value Stock Right Now?
finance.yahoo.com - December 29 at 3:14 PM |
| Vir Biotechnology shares are trading lower after Baird downgraded the stock from Neutral to Underperform.
benzinga.com - December 23 at 5:38 AM |
| Biotech Stock Roundup: Regulatory Updates From BIIB, AMGN and NVAX & More
msn.com - December 22 at 12:39 PM |
|
| Time To Worry? Analysts Just Downgraded Their Vir Biotechnology, Inc. (NASDAQ:VIR) Outlook
finance.yahoo.com - December 22 at 7:38 AM |
| Where Vir Biotechnology Stands With Analysts
benzinga.com - December 21 at 3:03 PM |
| Thinking about trading options or stock in Moderna, Vir Biotechnology, BioNTech, Cerner Corp, or Apple?
benzinga.com - December 20 at 1:16 PM |
| Vir (VIR), Glaxo's Xevudy Wins EC Approval for COVID-19
finance.yahoo.com - December 20 at 1:16 PM |
 | Vir And GSK's Sotrovimab Gets EC Marketing Authorization For Early Treatment Of Covid-19
nasdaq.com - December 17 at 12:34 PM |
| Glaxo-Vir Biotech's Antibody Approved In Europe For Early Treatment Of COVID-19
msn.com - December 17 at 12:34 PM |
| Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
finance.yahoo.com - December 17 at 8:31 AM |
| Vir Biotechnology's Stock Rally Seems To Have More Runway Left
benzinga.com - December 16 at 5:12 PM |
 | Premarket Movers: Confluent, Accenture Cl A, Vir Biotechnology
barrons.com - December 16 at 7:48 AM |
| Why Are Vir Biotech Shares Gaining Today?
finance.yahoo.com - December 15 at 3:54 PM |
| Vir Biotechnology Surges on Evidence Therapy Useful Against Omicron
finance.yahoo.com - December 15 at 3:54 PM |
| Publicly traded biotech firm expands to St. Louis with new Cortex office
finance.yahoo.com - December 15 at 3:54 PM |
| Vir and Glaxo’s Drug Could Be the Last Antibody Treatment Standing Against Omicron
barrons.com - December 15 at 10:34 AM |
| Thinking about trading options or stock in Vir Biotechnology, Pfizer, Apple, Tesla, or AMC Entertainment?
benzinga.com - December 14 at 11:24 PM |
| Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its Effect on the Neutralizing Activity of Monoclonal Antibodies, Convalescent Antibodies and Vaccine-Elicited Antibodies
finance.yahoo.com - December 14 at 6:23 PM |
| Premarket Movers: Vir Biotechnology, Bank of Montreal, AMC Entertainment Hldgs
barrons.com - December 14 at 8:22 AM |
| Vir Biotechnology Announces Initiation of Phase 2 Clinical Trial Evaluating VIR-2218, Selgantolimod and Nivolumab for the Treatment of Chronic Hepatitis B Virus Infection
finance.yahoo.com - December 9 at 8:45 AM |
